CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

← H02.2

Chapter 7 - Diseases of the eye and adnexa (H00-H59)»Disorders of eyelid, lacrimal system and orbit (H00-H05)»Paralytic lagophthalmos (H02.23)

H02.23

Paralytic lagophthalmos

Sub-codes (10)

  • H02.231 Paralytic lagophthalmos right upper eyelid
  • H02.232 Paralytic lagophthalmos right lower eyelid
  • H02.233 Paralytic lagophthalmos right eye, unspecified eyelid
  • H02.234 Paralytic lagophthalmos left upper eyelid
  • H02.235 Paralytic lagophthalmos left lower eyelid
  • H02.236 Paralytic lagophthalmos left eye, unspecified eyelid
  • H02.239 Paralytic lagophthalmos unspecified eye, unspecified eyelid
  • H02.23A Paralytic lagophthalmos right eye, upper and lower eyelids
  • H02.23B Paralytic lagophthalmos left eye, upper and lower eyelids
  • H02.23C Paralytic lagophthalmos, bilateral, upper and lower eyelids

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.